MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Rhythmic movements decompose in Parkinson’s disease with worse disease severity at low frequencies: akinesia or impaired ability to move more slowly than comfortable?

    S. Israeli-Korn, A. Korakin, N. Vaadia, S. Hassin-Baer, J. Friedman (Tel Hashomer, Israel)

    Objective: To explore the relationship between disease severity, minimum comfortable velocity and dwell time in Parkinson's disease. Background: People find it hard to move smoothly…
  • MDS Virtual Congress 2020

    The dysfunctional autonomic function and “dysfunctional” fatigue in drug naïve Parkinson’s disease

    J.H Ahn, M. Kim, J.K Mun, J.S Kim, J. Song, J. Youn, J.S Kim, J.W Cho (Seoul, Republic of Korea)

    Objective: In the present study, the relationship between fatigue and autonomic dysfunction in drug-naïve PD patients was investigated. Background: Fatigue is a common and disabling…
  • MDS Virtual Congress 2020

    Clinical characteristics of pain in Parkinson’s disease dementia

    B. Ciopleias, S. Diaconu, R. Chiujdea, C. Falup-Pecurariu (Braşov, Romania)

    Objective: The aim of this study was the assess the prevalence of pain in Parkinson’s disease dementia, its clinical characteristics, and correlations with motor part…
  • MDS Virtual Congress 2020

    Long-term quality of life after subthalamic deep brain stimulation depends on non-motor symptoms in Parkinson’s disease

    S. Jost, L. Timmermann, A. Rizos, M. Silverdale, J. Evans, P. Loehrer, M. Samuel, J. Petry-Schmelzer, A. Sauerbier, M. Barbe, G. Fink, V. Visser-Vandewalle, K. Ashkan, A. Antonini, P. Martinez-Martin, K. Ray Chaudhuri, H. Dafsari (Cologne, Germany)

    Objective: To predict 36-month follow-up quality of life (QoL) outcome after bilateral subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson’s disease (PD). Background: STN-DBS improves…
  • MDS Virtual Congress 2020

    Is acoustic speech analysis applicable for evaluation of swallowing impairment in patients with Parkinson’s disease (PD)?

    N. Madetko, S. Budrewicz (Wrocław, Poland)

    Objective: More than 80% of patients with Parkinson’s disease develop dysphagia during the course of the disease. Methods considered as ‘gold standard’ in swallowing evaluation…
  • MDS Virtual Congress 2020

    Effects of Co-Morbidities on Sleep Patterns in Parkinson’s Disease: A Study of 84 Ibadan Patients

    R. Oguntoye (Ibadan, Nigeria)

    Objective: To assess the effects of co-morbidities on sleep patterns in PD. Background: Parkinson’s disease is a progressive neurodegenerative disease. The non-motor symptoms are said…
  • MDS Virtual Congress 2020

    The non-declaration of musculoskeletal pain in Parkinson’s disease in patient-related outcome measures –The King’s experience

    K. Rukavina, M. Krbot Skoric, C. Borley, L. Batzu, A. Rizos, D. van Wamelen, K. Ray Chaudhuri (London, United Kingdom)

    Objective: To determine the usefulness of patient related outcome (PRO) measures in highlighting non-declaration of pain, a challenging non-motor symptom (NMS) of Parkinson’s disease (PD).…
  • MDS Virtual Congress 2020

    Dysphasia as a novel approach for classification of speech disorders in Parkinson’s disease and other forms of neurodegeneration

    E. Vasenina, O. Levin (Moscow, Russian Federation)

    Objective: To classify and identify the features of speech disorders in Parkinson's disease and other neurodegenerative diseases. Background: No unified approach to classification and diagnostics…
  • MDS Virtual Congress 2020

    The interaction of Parkin and TAF15 for the Drosophila in which neuronal defect was induced

    E.J Choi, D.G Lee, CC. Cui, K.Y Kim (Ulsan, Republic of Korea)

    Objective: Our study proposes a novel regulator for the protection of TAF15-induced proteinopathy and adds to our understanding of the exact pathogenic mechanism for TAF15-induced…
  • MDS Virtual Congress 2020

    Pulmonary function in Parkinson’s disease

    A. O'Callaghan, W. Gray, S. Bourke, R. Walker (North Shields, United Kingdom)

    Objective: To establish if pulmonary function is impaired in Parkinson’s disease (PD) and define any pattern of impairment. Background: Parkinson’s disease (PD) is associated with…
  • « Previous Page
  • 1
  • …
  • 73
  • 74
  • 75
  • 76
  • 77
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Welcome to the MDS Abstracts Site
  • Effect of marijuana on Essential Tremor: A case report
  • Advanced Search
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley